(Q37335068)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19034327%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Effects of calcimimetics on extraskeletal calcifications in chronic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19034327%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19034327%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Escolástico Aguilera-Tejero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19034327%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

F Javier Mendoza

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19034327%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Fátima Guerrero

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19034327%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ignacio López

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19034327%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19034327%20AND%20SRC:MED&resulttype=core&format=json

Kidney International. Supplement

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19034327%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19034327%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

S50-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19034327%20AND%20SRC:MED&resulttype=core&format=json

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Biology of calcification in vascular cells: intima versus media

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Medial arterial calcification and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Atherosclerosis and arteriosclerosis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Epidemiology of peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Arterial stiffening and vascular calcifications in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Pathophysiology of vascular calcification in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Vascular calcification: in vitro evidence for the role of inorganic phosphate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Vascular calcification mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Italian Group for the Study of Intravenous Calcitriol

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

1,25-Dihydroxyvitamin D3 stimulates 45Ca2+-uptake by cultured vascular smooth muscle cells derived from rat aorta

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Aortic calcification produced by vitamin D3 plus nicotine.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Vitamin D receptor activators can protect against vascular calcification

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: correlation with posttranslational modification of the trans acting factor AUF1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Matrix gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Extracellular calcium-sensing receptor is functionally expressed in human artery

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Successful treatment of calciphylaxis with intravenous sodium thiosulfate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Sodium thiosulphate as a promising therapeutic option to treat calciphylaxis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: case report

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Intraperitoneal Sodium Thiosulfate for the Treatment of Calciphylaxis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Successful treatment of calciphylaxis with cinacalcet-an alternative to parathyroidectomy?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021

Massive soft tissue calcifications and cinacalcet

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.546

7 January 2021